Insider Transactions in Q4 2025 at Emergent Bio Solutions Inc. (EBS)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 14
2025
|
Simon C Lowry SVP, R&D, CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,543
-3.85%
|
$38,973
$11.41 P/Share
|
|
Dec 05
2025
|
Ronald Richard Director |
SELL
Open market or private sale
|
Direct |
21,984
-9.93%
|
$263,808
$12.01 P/Share
|
|
Dec 05
2025
|
Ronald Richard Director |
SELL
Payment of exercise price or tax liability
|
Direct |
10,864
-8.75%
|
$119,504
$11.9 P/Share
|
|
Dec 05
2025
|
Ronald Richard Director |
BUY
Exercise of conversion of derivative security
|
Direct |
25,748
+17.18%
|
$128,740
$5.02 P/Share
|
|
Nov 11
2025
|
William Hartzel SVP, Bioservices |
SELL
Payment of exercise price or tax liability
|
Direct |
610
-0.59%
|
$6,100
$10.88 P/Share
|
|
Nov 10
2025
|
Donald W De Golyer Director |
SELL
Open market or private sale
|
Direct |
17,801
-12.93%
|
$178,010
$10.54 P/Share
|
|
Nov 07
2025
|
Sujata Tyagi Dayal Director |
SELL
Open market or private sale
|
Direct |
8,552
-8.77%
|
$85,520
$10.0 P/Share
|
|
Oct 15
2025
|
Richard S Lindahl EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,995
-1.68%
|
$44,955
$9.6 P/Share
|
|
Oct 07
2025
|
Coleen Glessner EVP, Quality & Ethics, and CPL |
SELL
Open market or private sale
|
Direct |
30,608
-17.5%
|
$306,080
$10.0 P/Share
|